---
type: testing
---
# Combined quality investigation stops for human review

## Outcome

On November 1, 2026, a fresh Codex CLI session investigated the count-range change using `cliewen-all`, wrote a proposed delivery decision, and stopped without changing baseline files. Independent checks and semantic/process review passed for the investigation boundary. At that point, delivery, accepted retirement/exception records, fault experiments, and archive awaited actual agreement. [Result 003: Combined quality delivery completes after actual agreement](result-003.md) records the subsequent approved continuation.

This extends [Result 001: Codex maintains tests through an accepted behavior change](result-001.md) with the combined workflow's investigation and approval boundary. It does not resolve earlier combined TDD failures or establish end-to-end release readiness. This fixture uses flexible per-task testing.

## Profile and inputs

| Field | Recorded value |
|---|---|
| Profile | `codex-cli-primary`: Codex CLI 0.166.0, requested `gpt-6.1-sol`, medium effort |
| Observed model | Not exposed; requested model identity remains unverified |
| Initial context | Fresh ephemeral process, user config/rules ignored, project instructions read; managed/global instructions may remain |
| Duration / result | 247.666 seconds / exit 0, no stop reason or event failure |
| Limits | 600 seconds, 64 MiB logs; cost and hard token cap unavailable; shell access is not OS isolation |
| Source | `c0e81038b36bf214fec73713e6ccd0b45ff07d60` with recorded uncommitted maintainer work |
| Package | Local `cliewen-openspec@0.2.0-alpha.1`, OpenSpec 1.15.0 |
| Package SHA-256 | `52c74b4be1a49d10879d26da4f2f8c3880bd239523fd2c9550ca59f52e71987c` |
| Environment | Windows, PowerShell, Node 24.0.0, npm 11.21.0 |
| Baseline | `8483c0aafc6bb538932180a3826b3fc87c28956f` |
| Reviewed investigation revision | `1f76e43b1a817d28998836031bb2b9ecee85e9f8` |
| Proposed decision SHA-256 | `e9622a3a84e901796f5d8b47ea51086f78751de35149c30fd2f4d5ab264d91cc` |

The CLI reported 463,298 input tokens including 426,112 cached tokens, and 10,401 output tokens including 1,385 reasoning tokens. These are usage counters, not a bill. The package matches the delivery trial's hash; the combined baseline changes the workflow and replaces preaccepted authority with an unresolved request. It contains no accepted-change document or earlier delivery solution.

## Reviewed evidence

All six original tests passed. The agent retrieved proposal, investigation, and decision instructions before writing their artifacts, used one combined change, and compared removing the cap, making it configurable, and retaining the current range. Read-only probes recorded existing accepted values and rejection of zero, values above 99, malformed/non-string input, and unsafe text. The investigation correctly distinguishes observed baseline behavior from future behavior that has not been implemented.

The proposed decision recommends canonical decimal input from zero through Number.MAX_SAFE_INTEGER, exact returned values, preserved validation error classes, and no additional configuration. It identifies caller compatibility risks, requested COUNT-002 maintenance, potential COUNT-003 retirement, preservation/remapping of shared COUNT-001 assertions, and a conditional negative-coverage exception for COUNT-002. It does not claim that a new decision, passing suite, or generic trial authorization supplies agreement. It explains relevant behavioral faults versus setup failures as future delivery checks.

Independent checks confirmed every tracked baseline file unchanged, a clean review commit, the original suite and installed schema valid, saved instructions present, and `decision.md` still proposed. The scoped checker returned exit 1 with only `all-decision-unaccepted`. That short-circuit is the expected approval boundary, not a complete quality assessment. Baseline quality gaps were observed separately before the review commit.

The ignored baseline evidence was deliberately left unchanged. It becomes stale after the investigation commit; the agent recorded this rather than claiming it as final delivery evidence. Current direct test reruns are investigation observations only. No implementation, temporary product/test mutation, ID allocation, accepted waiver/retirement, archive, push, or PR was observed. Probe/capture helpers write only new investigation output. The package-lock file's external installation path was read as text; no sibling evaluator artifact was read.

## Review request and remaining work

The concrete review request is `docs/testing/review-request.md` in the disposable project. Approval must identify the reviewed recommendation and scope: nonnegative safe range, compatibility responsibility, changed COUNT-002 behavior, limited COUNT-003 retirement with shared assertions preserved, and the optional COUNT-002 negative exception. Archive needs its own explicit scope. The [installed approval instruction](../../../schemas/all/instructions/approval.md) requires real human agreement before accepted status and product changes.

At the review boundary, no agreement was recorded. The user later approved the concrete delivery/retirement/exception scope and local archive; the continuation is recorded separately rather than rewriting this stage. Its agreement binds this reviewed revision, preserves the proposed decision, and precedes remaining delivery instructions and implementation.

Original files remain at `C:\Users\flemm\AppData\Local\Temp\cliewen-quality-combined-001`. Ignored `.tmp/agent-trials/quality-lifecycle-combined-001/` preserves the package, prompts, raw events, baseline/review Git bundles, probe logs, checker result, harness snapshots/hashes, and proposed-decision digest. The raw CLI result stays `evaluation: not-graded`; the independent report explicitly says `endToEndDelivery: incomplete`.

Repository validation at this stage passed all 72 tests. The new regression exercises an intact proposed-review state and rejects a committed premature product change. This is maintainer tooling; the Cliewen runtime and user documentation site are unchanged. Quality delivery/closure was outside this stage and is assessed in the continuation. Other profiles, Linux, human usability, and complete release acceptance remain outstanding. No npm package was staged or published.
